Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Biel

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
EMBO Molecular Medicine|February 22, 2021
Novel AAV capsids for intravitreal gene therapy of photoreceptor disordersMarina Pavlou, Christian Schön, Laurence M Occelli, et al.
Science (New York, N.Y.)|June 26, 2010
Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosaVolker Busskamp, Jens Duebel, David Balya, et al.
JCI Insight|May 3, 2019
Abolishing cAMP sensitivity in HCN2 pacemaker channels induces generalized seizuresVerena Hammelmann, Marc Sebastian Stieglitz, Henrik Hülle, et al.
Neuropharmacology|April 10, 2020
Neuropathic and cAMP-induced pain behavior is ameliorated in mice lacking CNGB1Wiebke Kallenborn-Gerhardt, Katharina Metzner, Ruirui Lu, et al.
Elife|November 28, 2018
Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cellsEva Plesch, Cheng-Chang Chen, Elisabeth Butz, et al.
Cell Chemical Biology|February 24, 2021
Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growthMartin Müller, Susanne Gerndt, Yu-Kai Chao, et al.
Nature Communications|January 12, 2022
MicroRNA-365 regulates human cardiac action potential durationDena Esfandyari, Bio Maria Ghéo Idrissou, Konstantin Hennis, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Human Molecular Genetics|April 3, 2017
Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2Stylianos Michalakis, Lior Shaltiel, Vithiyanjali Sothilingam, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
EMBO Molecular Medicine|February 22, 2021
Novel AAV capsids for intravitreal gene therapy of photoreceptor disordersMarina Pavlou, Christian Schön, Laurence M Occelli, et al.
Science (New York, N.Y.)|June 26, 2010
Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosaVolker Busskamp, Jens Duebel, David Balya, et al.
JCI Insight|May 3, 2019
Abolishing cAMP sensitivity in HCN2 pacemaker channels induces generalized seizuresVerena Hammelmann, Marc Sebastian Stieglitz, Henrik Hülle, et al.
Neuropharmacology|April 10, 2020
Neuropathic and cAMP-induced pain behavior is ameliorated in mice lacking CNGB1Wiebke Kallenborn-Gerhardt, Katharina Metzner, Ruirui Lu, et al.
Elife|November 28, 2018
Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cellsEva Plesch, Cheng-Chang Chen, Elisabeth Butz, et al.
Cell Chemical Biology|February 24, 2021
Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growthMartin Müller, Susanne Gerndt, Yu-Kai Chao, et al.
Nature Communications|January 12, 2022
MicroRNA-365 regulates human cardiac action potential durationDena Esfandyari, Bio Maria Ghéo Idrissou, Konstantin Hennis, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Human Molecular Genetics|April 3, 2017
Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2Stylianos Michalakis, Lior Shaltiel, Vithiyanjali Sothilingam, et al.
Pageof 20